ArticleACS chemical biology2019

Exploiting CD22 To Selectively Tolerize Autoantibody Producing B-Cells in Rheumatoid Arthritis.

Kyle J Bednar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.